Abstract

Acute myocardial infarction (AMI) leads to localized cardiac ischemia and can be fatal if untreated. Despite being treatable, the threat of ischemia-reperfusion (IR) injury remains high. Mitochondria are central to both propagation and mitigation of IR injury, and cardiac mitochondria are categorized into two major subtypes—subsarcolemmal and interfibrillar mitochondria (SSM and IFM, respectively). We hypothesized that, in our pre-clinical porcine model of AMI, SSM and IFM are differentially affected by reperfusion. AMI was induced in female pigs by balloon occlusion of the left anterior descending artery for 45 min, followed by 4 h of reperfusion. At the end of reperfusion, animals were euthanized. Cardiac SSM and IFM from the affected ischemic area and a nearby non-ischemic area were isolated to compare mitochondrial function using substrates targeting mitochondrial electron transport chain complexes I and II. Despite detecting overall significant differences in mitochondrial function including yield, mitochondrial S3 and S4 respirations, and calcium retention, consistent individual functional differences in the two mitochondrial subpopulations were not observed, both between the two mitochondrial subtypes, as well as between the ischemic and non-ischemic tissue. Nonetheless, this study describes the mitochondrial subtype response within the initial few hours of reperfusion in a clinically relevant model of AMI, which provides valuable information needed to develop novel mitochondrially targeted therapies for AMI.

Highlights

  • Cardiovascular disease is the leading cause of death in the United States and worldwide

  • The median ejection fraction was at 60% (55, 60) at baseline and significantly reduced to 35% (23, 53) at 4 h of reperfusion

  • We described the effect of Acute myocardial infarction (AMI) on the two cardiac mitochondrial subpopulations in a clinically relevant large animal model

Read more

Summary

Introduction

Cardiovascular disease is the leading cause of death in the United States and worldwide. AMI occurs when there is a sudden cessation of blood flow to a region of the heart muscle due to partial or complete occlusion of a major coronary artery. Preclinical AMI and Mitochondrial Subpopulations increases the risk of other adverse cardiac events including arrhythmia, heart failure, cardiac arrest and death (Zaman and Kovoor, 2014). Current treatments for AMI include percutaneous coronary interventions (PCI) using balloon angioplasty, and when not available, the use of thrombolytics to dissolve blood clots and re-establish blood flow (Arntz, 2008; Armstrong et al, 2013; O’Gara et al, 2013; Vogel et al, 2019). A severe form of AMI, ST-elevation myocardial infarction (STEMI), is caused when the coronary artery is completely occluded, leading to irreversible necrosis of the affected tissue. STEMI is characterized by elevation in the ST-segment in the electrocardiogram (ECG) (Ibanez et al, 2018)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call